CVS News Alert CVS Corp (CVS) 97.89 12/25/2014 19:31:22

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CVS Corp (CVS) 97.89 $CVS

Continued Increase In Sales Earns CVS A Bullish Thesis
Equity Watch - at Seeking Alpha - Thu Dec 25, 2:08AM CST

CVS: 97.89 (+0.02)

Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)

CVS Caremark Has Returned 24.7% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Wed Dec 24, 9:42AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 5 months, CVS Caremark has returned 24.69% as of today's recent price of $97.98.
CVS: 97.89 (+0.02)

Update: Walgreen Earnings Put The Green In Walgreen
The Specialist - at Seeking Alpha - Tue Dec 23, 1:39PM CST

CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Walgreen Q1 Earnings Top On Strong Prescription Sales
at Investor's Business Daily - Tue Dec 23, 10:50AM CST
A record number of prescriptions helped boost Walgreen 's (WAG) first-quarter results above analyst estimates. On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were...
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Today's Market: Moving Higher On Strong Earnings And Pricing Power
Matthew Smith - at Seeking Alpha - Tue Dec 23, 10:48AM CST

SPY: 207.77 (+0.02), HTZ: 24.38 (-0.09), JPM: 62.48 (unch), GMCR: 137.65 (+1.10), DIA: 180.03 (unch), SNE: 21.32 (+0.46), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)

Express Scripts Hates Gilead Sciences, Loves AbbVie
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 10:22AM CST
Source: Express Scripts When Gilead Sciences won approval last winter for its game-changing hepatitis C drug, Sovaldi, healthcare payers recoiled at Sovaldi's $1,000 per pill pricing. Express Scripts offered one of the loudest voices of...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02)

Jim Cramer on the Markets: Some Stocks You Just Can't Ignore
at The Street - Tue Dec 23, 9:03AM CST
And stop chasing stocks that won't let you in.
FDX: 176.42 (-0.52), MMM: 166.96 (+0.09), SWKS: 74.32 (+0.92), NKE: 96.29 (+0.32), HON: 101.96 (-0.02), DIS: 94.42 (-0.27), BA: 131.24 (+1.21), MS: 38.81 (-0.14), AA: 15.77 (+0.04), CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), COST: 143.65 (-0.50), CVS: 97.89 (+0.02), MCD: 93.83 (-0.39), GOOGL: 536.93 (-1.84), ROST: 92.72 (-0.60)

Rite Aid: A Classic Value Trap
James Godbout - at Seeking Alpha - Tue Dec 23, 8:33AM CST

CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

'Fast Money' Recap: The World's Investment Money Is Coming to the U.S.
at The Street - Tue Dec 23, 4:00AM CST
The trading panel discussed stocks, the price of oil, Twitter and Abbvie's price cuts on hepatitus C drugs.
BID: 43.31 (+0.01), XOP: 49.05 (-0.89), FB: 80.77 (+0.16), BBRY: 10.67 (-0.13), WMT: 86.43 (-0.23), TIF: 107.27 (+0.28), INTC: 37.44 (+0.01), TLT: 123.95 (+0.41), TCO: 75.81 (-0.37), SBUX: 81.27 (-0.16), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), QCOM: 74.66 (+0.06), TGT: 74.65 (-0.04), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), GOOGL: 536.93 (-1.84), TWTR: 37.61 (+0.04)

Watch for CVS Caremark to Potentially Pullback After Gaining 1.47% Yesterday
Comtex SmarTrend(R) - Mon Dec 22, 4:02PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.76 to a high of $97.11. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $96.73 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.89 (+0.02)

Look for Shares of CVS Caremark to Potentially Pullback after Yesterday's 1.47% Rise
Comtex SmarTrend(R) - Mon Dec 22, 4:01PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.76 to a high of $97.11. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $96.73 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.89 (+0.02)

The 3 Best Ways to Invest In Real Estate
Motley Fool Staff - Motley Fool - Mon Dec 22, 1:01PM CST
Real estate can be a great investment and has the potential for excellent income and long-term growth. However, buying investment properties is not for everyone. We asked three of our analysts for their favorite way to invest in real estate, and...
HCP: 44.00 (-0.45), NNN: 40.27 (+0.15), STI: 42.43 (-0.18), CVS: 97.89 (+0.02), RLGY: 43.91 (+0.39)

Walgreen Lags CVS Health, but Both Are Technically Overbought
at The Street - Mon Dec 22, 12:34PM CST
CVS Health expanded its Minute Clinic and quit selling cigarettes, while Walgreen still sells smokes and will move to the Nasdaq after completing a merger. Here's how to trade them.
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)

Rite Aid After Earnings: Alive To Fight Another Day
Hunter Straus - at Seeking Alpha - Mon Dec 22, 8:45AM CST

CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

3 Reasons Rite Aid Corporation's Stock Could Soar in 2015
Keith Speights, The Motley Fool - Motley Fool - Mon Dec 22, 7:02AM CST
Rite Aid Corporation shareholders can celebrate big gains of more than 30% for 2015 headed into the last few days of the year thanks in part to a blow-out third quarter. However, some investors might still be disappointed. Why? Because the stock of...
MCK: 209.79 (+0.58), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Should You Consider Walgreen For The Trifecta?
The Specialist - at Seeking Alpha - Sun Dec 21, 2:53PM CST

CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Walgreen Earnings Due Amid Merger, Management Shakeup
at Investor's Business Daily - Sun Dec 21, 7:02AM CST
Investors will look for signs of renewed growth at Walgreen (WAG) when it reports first-quarter financial results Tuesday after just barely meeting expectations last quarter. The report comes amid a shakeup in top Walgreen management as it enters the...
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Retail trends to watch: Athleisure, P-E buyouts, and new online channels
Seeking Alpha - at Seeking Alpha - Sat Dec 20, 9:17AM CST

SPLS: 17.82 (-0.01), AMZN: 303.03 (-3.26), NKE: 96.29 (+0.32), DKS: 49.47 (-0.30), ANN: 38.11 (+0.58), WSM: 75.32 (-0.61), ARO: 2.30 (-0.03), XRT: 95.24 (-0.06), LULU: 54.40 (-0.16), RAD: 7.26 (-0.09), UA: 67.97 (+0.18), ANF: 28.06 (-0.17), CVS: 97.89 (+0.02), ODP: 8.75 (+0.06), ULTA: 128.18 (-0.38), WAG: 76.67 (+0.16), PETM: 81.16 (+0.03)

Jim Cramer Identifies Buying Opportunity in Walgreen (WAG) Stock After Earnings Next Week
at The Street - Fri Dec 19, 11:51AM CST
TheStreet's Jim Cramer explains when to buy Walgreen (WAG) stock after earnings next week.
CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Study Reveals Stark Disparities in Education Equity

Updated Category News Views 5

Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...

Continue Reading
2026 Global Ocean Forum Unveils Key Marine Strategies

Updated Category News Views 34

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

Continue Reading
Quad Sees Marginal Gains Amid Industry Challenges

Updated Category News Views 63

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Continue Reading
Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Updated Category News Views 46

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 66

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 33

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading
Nikon Unveils Game-Changing Zoom Lens for Pros

Updated Category News Views 35

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

Continue Reading
E. Coli Outbreaks Spark Push for New Petting Zoo Laws

Updated Category News Views 0

A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...

Continue Reading
Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Neuboron Medical Group Sets the Stage for Cancer Treatment Innovation

Updated Category News Views 208

Introduction to Neuboron Medical Group's Innovations Neuboron Medical Group is at the forefront of revolutionizing cancer treatment through its advanced use of Boron Neutron Capture Therapy (BNCT). This technology has gained momentum worldwide, and Neuboron is making significant strides with the creation of China's first accelerator-based BNCT demonstration center in...

Continue Reading
European Market Update: Mixed Results in French Trading Session

Updated Category News Views 141

As the trading session wrapped up in France, it was clear: the stock market painted a pretty chaotic picture. The CAC 40 index took a hit, dropping by 2.00%. Meanwhile, the SBF 120 index managed to climb a bit, up by 0.66%. This kind of mixed performance suggests investors were split—some panicking while others sniffed out opportunities in the mayhem. CAC 40 Drama: Top...

Continue Reading
Man Group Reports Key Position Details in Darktrace Acquisition

Updated Category News Views 105

Man Group’s Position Disclosure Regarding Darktrace Man Group PLC has recently published a notable disclosure concerning its interests in Darktrace plc, which has sparked interest among investors and market analysts. This move complies with Rule 8.3 of the Takeover Code, which requires transparency about positions in relevant securities. Let’s take a closer look at...

Continue Reading
Apollo's Strategic Fund Closure Signals Confidence in Credit Markets

Updated Category News Views 238

Apollo's Strategic Fund Closure Signals Confidence in Credit Markets In a bold move that reflects confidence in the evolving financial landscape, Apollo recently closed on $8.5 billion in total commitments for its Accord+ strategy. This remarkable achievement includes a significant $4.8 billion earmarked for the Accord+ Fund II, demonstrating not only robust investor...

Continue Reading
Perseus Mining's Bold Move to Purchase Predictive Discovery

Updated Category News Views 231

Perseus Mining Makes a Strategic Move with Predictive Discovery Perseus Mining Limited (ASX/TSX: PRU) has announced an exciting proposal to acquire Predictive Discovery Limited (ASX: PDI), a bold step that highlights its commitment to growth in the mining sector. This proposed acquisition involves a definitive binding offer for all issued shares in Predictive Discovery...

Continue Reading